These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36178162)

  • 41. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis.
    Szarpak L; Filipiak KJ; Gasecka A; Gawel W; Koziel D; Jaguszewski MJ; Chmielewski J; Gozhenko A; Bielski K; Wroblewski P; Savytskyi I; Szarpak L; Rafique Z
    Cardiol J; 2022; 29(2):188-196. PubMed ID: 34642923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study.
    Annweiler G; Corvaisier M; Gautier J; Dubée V; Legrand E; Sacco G; Annweiler C
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33147894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin D3 as Potential Treatment Adjuncts for COVID-19.
    Malaguarnera L
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33202670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: a double-blind randomised controlled trial.
    Seely D; Legacy M; Conte E; Keates C; Psihogios A; Ramsay T; Fergusson DA; Kanji S; Simmons JG; Wilson K
    BMJ Open; 2023 Sep; 13(9):e073761. PubMed ID: 37739466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Traditional herbs against COVID-19: back to old weapons to combat the new pandemic.
    Al-Kuraishy HM; Al-Fakhrany OM; Elekhnawy E; Al-Gareeb AI; Alorabi M; De Waard M; Albogami SM; Batiha GE
    Eur J Med Res; 2022 Sep; 27(1):186. PubMed ID: 36154838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease.
    Malle L; Gao C; Hur C; Truong HQ; Bouvier NM; Percha B; Kong XF; Bogunovic D
    Genet Med; 2021 Mar; 23(3):576-580. PubMed ID: 33060835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility.
    Daei Sorkhabi A; Sarkesh A; Daei Sorkhabi A; Entezari-Maleki T; Rashedi J; Bannazadeh Baghi H
    J Basic Clin Physiol Pharmacol; 2021 Aug; 33(1):55-77. PubMed ID: 34380185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease.
    De Nicolò A; Cusato J; Bezzio C; Saibeni S; Vernero M; Disabato M; Caviglia GP; Ianniello A; Manca A; D'Avolio A; Ribaldone DG
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perception, knowledge, and consumption pattern of dietary supplement used during COVID-19 pandemic among black Africans: Perspective of Nigerians.
    Holdbrooke SJA; Afolabi BM; David NA; Kareem KO; Salako A; Aina OO
    Dialogues Health; 2023 Dec; 2():100106. PubMed ID: 36744009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results.
    Meltzer DO; Best TJ; Zhang H; Vokes T; Arora V; Solway J
    JAMA Netw Open; 2020 Sep; 3(9):e2019722. PubMed ID: 32880651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin D to prevent COVID-19: recommendations for the design of clinical trials.
    Camargo CA; Martineau AR
    FEBS J; 2020 Sep; 287(17):3689-3692. PubMed ID: 33448695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19?
    Shakoor H; Feehan J; Al Dhaheri AS; Ali HI; Platat C; Ismail LC; Apostolopoulos V; Stojanovska L
    Maturitas; 2021 Jan; 143():1-9. PubMed ID: 33308613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arkansans' Preferred COVID-19 Testing Locations.
    McElfish PA; Willis DE; Bryant-Moore K; Rojo MO; Andersen JA; Kaminicki KF; James LP
    J Prim Care Community Health; 2021; 12():21501327211004289. PubMed ID: 33771056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating knowledge, habits, and beliefs regarding dietary supplements as a protective measure against COVID-19 in Malaysia and Iraq: A postsecond wave cross-sectional analysis.
    Mohammed AH; Hassan BAR; Blebil A; Dujaili J; Wayyes AM; Abdulhamid OA; Salih HS; Al-Jewari WM; Hassan HS; Lim A
    Health Sci Rep; 2024 Feb; 7(2):e1865. PubMed ID: 38343667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.